HCWB
Income statement / Annual
Last year (2023), HCW Biologics Inc.'s total revenue was $2.84 M,
a decrease of 57.72% from the previous year.
In 2023, HCW Biologics Inc.'s net income was -$24.99 M.
See HCW Biologics Inc.�s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$2.84 M
|
$6.72 M
|
$0.00
|
$4.10 M
|
$0.00
|
| Cost of Revenue |
$2.28 M |
$4.14 M |
$543,598.00 |
$0.00 |
$421,817.00 |
| Gross Profit |
$560,360.00 |
$2.59 M |
-$543,598.00 |
$4.10 M |
-$421,817.00 |
| Gross Profit Ratio |
0.2 |
0.38 |
0 |
1 |
0 |
| Research and Development
Expenses |
$7.68 M
|
$9.34 M
|
$8.17 M
|
$7.26 M
|
$5.39 M
|
| General & Administrative
Expenses |
$13.08 M
|
$8.33 M
|
$4.98 M
|
$2.44 M
|
$1.80 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$13.08 M
|
$8.33 M
|
$4.98 M
|
$2.44 M
|
$1.80 M
|
| Other Expenses |
$5.52 M |
$304,735.00 |
$218,466.00 |
$233,039.00 |
$171,418.00 |
| Operating Expenses |
$26.28 M |
$17.67 M |
$13.37 M |
$9.92 M |
$7.37 M |
| Cost And Expenses |
$28.56 M |
$21.80 M |
$13.37 M |
$9.92 M |
$7.37 M |
| Interest Income |
$0.00 |
$126,660.00 |
$505,366.00 |
$22,324.00 |
$72,353.00 |
| Interest Expense |
$283,042.00 |
$126,660.00 |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$1.14 M
|
$589,608.00
|
$543,598.00
|
$572,867.00
|
$421,817.00
|
| EBITDA |
-$23.58 M
|
-$14.18 M
|
-$12.82 M
|
-$5.25 M
|
-$6.94 M
|
| EBITDA Ratio |
-8.3 |
-2.2 |
0 |
-1.28 |
0 |
| Operating Income Ratio
|
-9.05
|
-2.24
|
0
|
-1.42
|
0
|
| Total Other
Income/Expenses Net |
$722,883.00
|
$178,075.00
|
$505,366.00
|
$22,324.00
|
$72,353.00
|
| Income Before Tax |
-$24.99 M |
-$14.90 M |
-$12.86 M |
-$5.80 M |
-$7.29 M |
| Income Before Tax Ratio
|
-8.8
|
-2.22
|
0
|
-1.42
|
0
|
| Income Tax Expense |
$0.00 |
-$178,075.00 |
-$505,366.00 |
-$22,324.00 |
-$72,353.00 |
| Net Income |
-$24.99 M |
-$14.72 M |
-$12.36 M |
-$5.78 M |
-$7.22 M |
| Net Income Ratio |
-8.8 |
-2.19 |
0 |
-1.41 |
0 |
| EPS |
-0.7 |
-0.41 |
-0.35 |
-0.16 |
-0.2 |
| EPS Diluted |
-0.7 |
-0.41 |
-0.35 |
-0.16 |
-0.2 |
| Weighted Average Shares
Out |
$35.93 M
|
$35.82 M
|
$35.77 M
|
$36.70 M
|
$36.70 M
|
| Weighted Average Shares
Out Diluted |
$35.93 M
|
$35.82 M
|
$35.77 M
|
$36.70 M
|
$36.70 M
|
| Link |
|
|
|
|
|
